{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:43:40Z","timestamp":1790772220081,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00284-022-02807-7","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T02:02:37Z","timestamp":1647396157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["SARS-CoV-2: Receptor and Co-receptor Tropism Probability"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0749-9548","authenticated-orcid":false,"given":"Narges","family":"Eslami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa Shiri","family":"Aghbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shamekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher","family":"Entezari-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid Sadri","family":"Nahand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl Jafari","family":"Sales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-5361","authenticated-orcid":false,"given":"Hossein Bannazadeh","family":"Baghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"issue":"12","key":"2807_CR1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3201\/eid1212.060401","volume":"12","author":"L-F Wang","year":"2006","unstructured":"Wang L-F et al (2006) Review of bats and SARS. Emerg Infect Dis 12(12):1834","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2807_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/135965350701200S01.1","volume":"12","author":"L Van der Hoek","year":"2007","unstructured":"Van der Hoek L (2007) Human coronaviruses: what do they cause? Antiviral Ther 12(2):651\u2013658","journal-title":"Antiviral Ther"},{"issue":"1","key":"2807_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"W-I Choi","year":"2021","unstructured":"Choi W-I et al (2021) Comparison of the clinical characteristics and mortality of adults infected with human coronaviruses 229E and OC43. Sci Rep 11(1):1\u20138","journal-title":"Sci Rep"},{"issue":"6","key":"2807_CR4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su S et al (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24(6):490\u2013502","journal-title":"Trends Microbiol"},{"issue":"9","key":"2807_CR5","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1002\/jmv.27102","volume":"395","author":"PS Aghbash","year":"2021","unstructured":"Aghbash PS et al (2021) Viral co-infections in COVID-19. J Med Virol 395(9):5310\u20135322","journal-title":"J Med Virol"},{"issue":"10223","key":"2807_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395(10223):497\u2013506","journal-title":"China Lancet"},{"issue":"10223","key":"2807_CR7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C et al (2020) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470\u2013473","journal-title":"Lancet"},{"issue":"9","key":"2807_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humimm.2021.05.001","volume":"82","author":"A Choudhury","year":"2021","unstructured":"Choudhury A, Mukherjee G, Mukherjee S (2021) Chemotherapy vs. Immunotherapy in combating nCOVID19: an update. Human Immunol 82(9):649\u2013658","journal-title":"Human Immunol"},{"key":"2807_CR9","doi-asserted-by":"crossref","first-page":"107331","DOI":"10.1016\/j.intimp.2020.107331","volume":"91","author":"PS Aghbash","year":"2021","unstructured":"Aghbash PS et al (2021) The role of Th17 cells in viral infections. Int Immunopharmacol 91:107331","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"2807_CR10","first-page":"138999","volume":"5","author":"Y Zuo","year":"2020","unstructured":"Zuo Y et al (2020) Neutrophil extracellular traps in COVID-19. JCI insight 5(11):138999","journal-title":"JCI insight"},{"issue":"2","key":"2807_CR11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 383(2):120\u2013128","journal-title":"N Engl J Med"},{"issue":"8","key":"2807_CR12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","volume":"382","author":"VJ Munster","year":"2020","unstructured":"Munster VJ et al (2020) A novel coronavirus emerging in China\u2014key questions for impact assessment. N Engl J Med 382(8):692\u2013694","journal-title":"N Engl J Med"},{"issue":"4","key":"2807_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.52142\/omujecm.38.4.44","volume":"38","author":"H Bannazadeh-Baghi","year":"2021","unstructured":"Bannazadeh-Baghi H et al (2021) Epidemiology, virology, clinical features, diagnosis, and treatment of SARS-CoV-2 infection. Journal of Experimental and Clinical Medicine 38(4):649\u2013668","journal-title":"Journal of Experimental and Clinical Medicine"},{"issue":"7808","key":"2807_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","volume":"581","author":"X Han","year":"2020","unstructured":"Han X et al (2020) Construction of a human cell landscape at single-cell level. Nature 581(7808):303\u2013309","journal-title":"Nature"},{"issue":"4","key":"2807_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15698\/cst2020.04.216","volume":"4","author":"D Raoult","year":"2020","unstructured":"Raoult D et al (2020) Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell stress 4(4):66","journal-title":"Cell stress"},{"issue":"6504","key":"2807_CR16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","volume":"369","author":"X Chi","year":"2020","unstructured":"Chi X et al (2020) A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 369(6504):650\u2013655","journal-title":"Science"},{"issue":"1","key":"2807_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2020.03.047","volume":"526","author":"J Luan","year":"2020","unstructured":"Luan J et al (2020) Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun 526(1):165\u2013169","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"2807_CR18","doi-asserted-by":"crossref","first-page":"e105114","DOI":"10.15252\/embj.2020105114","volume":"39","author":"S Lukassen","year":"2020","unstructured":"Lukassen S et al (2020) SARS-CoV-2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells. The EMBO journal 39(10):e105114","journal-title":"The EMBO journal"},{"issue":"4","key":"2807_CR19","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1128\/JVI.02615-14","volume":"89","author":"F Li","year":"2015","unstructured":"Li F (2015) Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol 89(4):1954\u20131964","journal-title":"J Virol"},{"issue":"9","key":"2807_CR20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y et al (2020) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41(9):1141\u20131149","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2807_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11(1):1\u201312","journal-title":"Nat Commun"},{"key":"2807_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-virology-122019-070025","volume":"7","author":"M Koehler","year":"2020","unstructured":"Koehler M et al (2020) Initial step of virus entry: virion binding to cell-surface glycans. Annu Rev Virol 7:143\u2013165","journal-title":"Annu Rev Virol"},{"issue":"2","key":"2807_CR23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/v13020262","volume":"13","author":"SV Kuchipudi","year":"2021","unstructured":"Kuchipudi SV et al (2021) Sialic acid receptors: the key to solving the enigma of zoonotic virus spillover. Viruses 13(2):262","journal-title":"Viruses"},{"issue":"22","key":"2807_CR24","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","volume":"88","author":"A Milewska","year":"2014","unstructured":"Milewska A et al (2014) Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J Virol 88(22):13221\u201313230","journal-title":"J Virol"},{"key":"2807_CR25","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of autoimmunity 109:102433","journal-title":"Journal of autoimmunity"},{"issue":"6485","key":"2807_CR26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R et al (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485):1444\u20131448","journal-title":"Science"},{"issue":"4\u20135","key":"2807_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.micinf.2020.03.003","volume":"22","author":"Y Qiu","year":"2020","unstructured":"Qiu Y et al (2020) Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2. Microbes Infect 22(4\u20135):221\u2013225","journal-title":"Microbes Infect"},{"issue":"10","key":"2807_CR28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/jmv.25987","volume":"92","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S (2020) In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol 92(10):2105\u20132113","journal-title":"J Med Virol"},{"key":"2807_CR29","doi-asserted-by":"crossref","first-page":"119124","DOI":"10.1016\/j.lfs.2021.119124","volume":"270","author":"PS Aghbash","year":"2021","unstructured":"Aghbash PS et al (2021) SARS-CoV-2 infection: the role of PD-1\/PD-L1 and CTLA-4 axis. Life Sciences 270:119124","journal-title":"Life Sciences"},{"issue":"6","key":"2807_CR30","first-page":"1011","volume":"120","author":"S Kim","year":"2021","unstructured":"Kim S et al (2021) Differential interactions between human ACE2 and spike RBD of SARS-CoV-2 variants of concern. J Chem Theory Comput. 120(6):1011","journal-title":"J Chem Theory Comput."},{"key":"2807_CR31","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3389\/fmed.2020.594495","volume":"7","author":"F Salamanna","year":"2020","unstructured":"Salamanna F et al (2020) Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front Med 7:935","journal-title":"Front Med"},{"issue":"10","key":"2807_CR32","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1042\/CS20200419","volume":"134","author":"SU Rehman","year":"2020","unstructured":"Rehman SU, Tabish M (2020) Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs. Clin Sci 134(10):1143\u20131150","journal-title":"Clin Sci"},{"issue":"12","key":"2807_CR33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","volume":"52","author":"OO Onabajo","year":"2020","unstructured":"Onabajo OO et al (2020) Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat Genet 52(12):1283\u20131293","journal-title":"Nat Genet"},{"issue":"4","key":"2807_CR34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/glycob\/cwaa101","volume":"31","author":"A Shajahan","year":"2021","unstructured":"Shajahan A et al (2021) Comprehensive characterization of N-and O-glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. Glycobiology 31(4):410\u2013424","journal-title":"Glycobiology"},{"key":"2807_CR35","doi-asserted-by":"crossref","first-page":"173701","DOI":"10.1016\/j.ejphar.2020.173701","volume":"890","author":"N Behloul","year":"2021","unstructured":"Behloul N et al (2021) In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain. Eur J Pharmacol 890:173701","journal-title":"Eur J Pharmacol"},{"key":"2807_CR36","doi-asserted-by":"crossref","first-page":"e61390","DOI":"10.7554\/eLife.61390","volume":"9","author":"NZ Cuervo","year":"2020","unstructured":"Cuervo NZ, Grandvaux N (2020) ACE2: evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife 9:e61390","journal-title":"Elife"},{"issue":"15","key":"2807_CR37","doi-asserted-by":"crossref","first-page":"167058","DOI":"10.1016\/j.jmb.2021.167058","volume":"433","author":"C Laffeber","year":"2021","unstructured":"Laffeber C et al (2021) Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants. J Mol Biol 433(15):167058","journal-title":"J Mol Biol"},{"key":"2807_CR38","doi-asserted-by":"crossref","first-page":"104759","DOI":"10.1016\/j.antiviral.2020.104759","volume":"177","author":"CJ Sigrist","year":"2020","unstructured":"Sigrist CJ, Bridge A, Le Mercier P (2020) A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Res 177:104759","journal-title":"Antiviral Res"},{"issue":"11","key":"2807_CR39","first-page":"2669","volume":"160","author":"HA Hussein","year":"2015","unstructured":"Hussein HA et al (2015) Beyond RGD: virus interactions with integrins. Adv Virol 160(11):2669\u20132681","journal-title":"Adv Virol"},{"issue":"8","key":"2807_CR40","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1128\/JVI.03491-13","volume":"88","author":"Y Wei","year":"2014","unstructured":"Wei Y et al (2014) Roles of the putative integrin-binding motif of the human metapneumovirus fusion (F) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol 88(8):4338\u20134352","journal-title":"J Virol"},{"issue":"12","key":"2807_CR41","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2967\/jnumed.120.255364","volume":"61","author":"CC Foster","year":"2020","unstructured":"Foster CC et al (2020) \u03b1v\u03b26-Targeted molecular PET\/CT imaging of the lungs after SARS-CoV-2 infection. J Nucl Med 61(12):1717\u20131719","journal-title":"J Nucl Med"},{"issue":"4","key":"2807_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc3701","volume":"14","author":"AS Lee","year":"2014","unstructured":"Lee AS (2014) Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nat Rev Cancer 14(4):263\u2013276","journal-title":"Nat Rev Cancer"},{"issue":"30","key":"2807_CR43","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1074\/jbc.RA118.001897","volume":"293","author":"H Chu","year":"2018","unstructured":"Chu H et al (2018) Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells. J Biol Chem 293(30):11709\u201311726","journal-title":"J Biol Chem"},{"issue":"3","key":"2807_CR44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.54055","volume":"17","author":"J Fu","year":"2021","unstructured":"Fu J et al (2021) Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19. Int J Biol Sci 17(3):897","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2807_CR45","doi-asserted-by":"crossref","first-page":"2001123","DOI":"10.1183\/13993003.01123-2020","volume":"56","author":"JA Aguiar","year":"2020","unstructured":"Aguiar JA et al (2020) Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue. Eur Respir J 56(3):2001123","journal-title":"Eur Respir J"},{"issue":"1","key":"2807_CR46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","volume":"9","author":"N Vankadari","year":"2020","unstructured":"Vankadari N, Wilce JA (2020) Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9(1):601\u2013604","journal-title":"Emerg Microbes Infect"},{"key":"2807_CR47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fendo.2019.00080","volume":"10","author":"CF Deacon","year":"2019","unstructured":"Deacon CF (2019) Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol 10:80","journal-title":"Front Endocrinol"},{"key":"2807_CR48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2016.00058","volume":"7","author":"H Noels","year":"2016","unstructured":"Noels H, Bernhagen J (2016) The CXCR4 ligand\/receptor family and the DPP4 protease in high-risk cardiovascular patients. Front Immunol 7:58","journal-title":"Front Immunol"},{"key":"2807_CR49","doi-asserted-by":"crossref","first-page":"119410","DOI":"10.1016\/j.lfs.2021.119410","volume":"276","author":"R Posadas-S\u00e1nchez","year":"2021","unstructured":"Posadas-S\u00e1nchez R et al (2021) Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19: association with disease and with severity. Life Sci 276:119410","journal-title":"Life Sci"},{"issue":"7809","key":"2807_CR50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel R et al (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581(7809):465\u2013469","journal-title":"Nature"},{"issue":"2","key":"2807_CR51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang S et al (2021) AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 31(2):126\u2013140","journal-title":"Cell Res"},{"issue":"11","key":"2807_CR52","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/all.14429","volume":"75","author":"U Radzikowska","year":"2020","unstructured":"Radzikowska U et al (2020) Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy 75(11):2829\u20132845","journal-title":"Allergy"},{"issue":"5","key":"2807_CR53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/jb\/mvv127","volume":"159","author":"T Muramatsu","year":"2016","unstructured":"Muramatsu T (2016) Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem 159(5):481\u2013490","journal-title":"J Biochem"},{"issue":"10","key":"2807_CR54","doi-asserted-by":"crossref","first-page":"17411","DOI":"10.3390\/ijms151017411","volume":"15","author":"L Xiong","year":"2014","unstructured":"Xiong L, Edwards CK, Zhou L (2014) The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature. Int J Mol Sci 15(10):17411\u201317441","journal-title":"Int J Mol Sci"},{"issue":"21","key":"2807_CR55","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1111\/bph.15166","volume":"177","author":"RR Rodrigues-Diez","year":"2020","unstructured":"Rodrigues-Diez RR et al (2020) Statins: could an old friend help in the fight against COVID-19? Br J Pharmacol 177(21):4873\u20134886","journal-title":"Br J Pharmacol"},{"issue":"4","key":"2807_CR56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2215\/CJN.09440620","volume":"16","author":"H Su","year":"2021","unstructured":"Su H et al (2021) Expression of CD147 and Cyclophilin A in kidneys of patients with COVID-19. Clin J Am Soc Nephrol 16(4):618\u2013619","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2807_CR57","doi-asserted-by":"crossref","first-page":"2001634","DOI":"10.1183\/13993003.01634-2020","volume":"56","author":"A Huertas","year":"2020","unstructured":"Huertas A et al (2020) Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respiratory Soc. 56(1):2001634","journal-title":"Eur Respiratory Soc."},{"issue":"1","key":"2807_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K et al (2020) CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther 5(1):1\u201310","journal-title":"Signal Transduct Target Ther"},{"issue":"6518","key":"2807_CR59","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"370","author":"JL Daly","year":"2020","unstructured":"Daly JL et al (2020) Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science 370(6518):861\u2013865","journal-title":"Science"},{"issue":"5","key":"2807_CR60","first-page":"4221","volume":"22","author":"J Davies","year":"2020","unstructured":"Davies J et al (2020) Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19. Mol Med Rep 22(5):4221\u20134226","journal-title":"Mol Med Rep"},{"issue":"1","key":"2807_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00460-9","volume":"6","author":"I Kyrou","year":"2021","unstructured":"Kyrou I et al (2021) Not only ACE2\u2014the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19. Signal Transduct Target Ther 6(1):1\u20133","journal-title":"Signal Transduct Target Ther"},{"key":"2807_CR62","unstructured":"Junjie G et al (2021) Neuropilin-1 mediates SARS-CoV-2 infection in bone marrow-derived macrophages. bioRxiv."},{"issue":"51","key":"2807_CR63","doi-asserted-by":"crossref","first-page":"eabd6197","DOI":"10.1126\/sciimmunol.abd6197","volume":"5","author":"ER Mann","year":"2020","unstructured":"Mann ER et al (2020) Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Science Immunology 5(51):eabd6197","journal-title":"Science Immunology"},{"issue":"3","key":"2807_CR64","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jmv.26515","volume":"93","author":"C Yang","year":"2021","unstructured":"Yang C et al (2021) Low serum calcium and phosphorus and their clinical performance in detecting COVID-19 patients. J Med Virol 93(3):1639\u20131651","journal-title":"J Med Virol"},{"issue":"6518","key":"2807_CR65","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L et al (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518):856\u2013860","journal-title":"Science"},{"issue":"1","key":"2807_CR66","doi-asserted-by":"crossref","first-page":"e1009153","DOI":"10.1371\/journal.ppat.1009153","volume":"17","author":"BS Mayi","year":"2021","unstructured":"Mayi BS et al (2021) The role of Neuropilin-1 in COVID-19. PLoS Pathogens 17(1):e1009153","journal-title":"PLoS Pathogens"},{"issue":"4","key":"2807_CR67","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/1574-6976.12052","volume":"38","author":"W Van Breedam","year":"2014","unstructured":"Van Breedam W et al (2014) Bitter-sweet symphony: glycan\u2013lectin interactions in virus biology. FEMS Microbiol Rev 38(4):598\u2013632","journal-title":"FEMS Microbiol Rev"},{"issue":"18","key":"2807_CR68","doi-asserted-by":"crossref","first-page":"18748","DOI":"10.1074\/jbc.M311227200","volume":"279","author":"W Liu","year":"2004","unstructured":"Liu W et al (2004) Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem 279(18):18748\u201318758","journal-title":"J Biol Chem"},{"issue":"5","key":"2807_CR69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","volume":"100","author":"TB Geijtenbeek","year":"2000","unstructured":"Geijtenbeek TB et al (2000) Identification of DC-SIGN, a novel dendritic cell\u2013specific ICAM-3 receptor that supports primary immune responses. Cell 100(5):575\u2013585","journal-title":"Cell"},{"key":"2807_CR70","doi-asserted-by":"crossref","unstructured":"Watanabe Y et al. (2020) Site-specific analysis of the SARS-CoV-2 glycan shield. BioRxiv.","DOI":"10.1101\/2020.03.26.010322"},{"issue":"1","key":"2807_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","volume":"14","author":"S Shen","year":"2021","unstructured":"Shen S et al (2021) SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism. J Hematol Oncol 14(1):1\u20135","journal-title":"J Hematol Oncol"},{"issue":"11","key":"2807_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14787210.2021.1915129","volume":"19","author":"SR Savla","year":"2021","unstructured":"Savla SR, Prabhavalkar KS, Bhatt LK (2021) Cytokine storm associated coagulation complications in COVID-19 patients: pathogenesis and management. Expert Rev Anti-Infective Therapy 19(11):1\u201317","journal-title":"Expert Rev Anti-Infective Therapy"},{"key":"2807_CR73","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148999","author":"Y Kondo","year":"2021","unstructured":"Kondo Y et al (2021) L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI insight. https:\/\/doi.org\/10.1172\/jci.insight.148999","journal-title":"JCI insight"},{"issue":"13","key":"2807_CR74","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.3390\/ijms21134675","volume":"21","author":"I Ramos","year":"2020","unstructured":"Ramos I et al (2020) Vimentin as a multifaceted player and potential therapeutic target in viral infections. Int J Mol Sci 21(13):4675","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2807_CR75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","volume":"5","author":"N Mor-Vaknin","year":"2003","unstructured":"Mor-Vaknin N et al (2003) Vimentin is secreted by activated macrophages. Nat Cell Biol 5(1):59\u201363","journal-title":"Nat Cell Biol"},{"issue":"14","key":"2807_CR76","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.3390\/ijms22147469","volume":"22","author":"DG Thalla","year":"2021","unstructured":"Thalla DG et al (2021) Role of extracellular vimentin in cancer-cell functionality and its influence on cell monolayer permeability changes induced by SARS-CoV-2 receptor binding domain. Int J Mol Sci 22(14):7469","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2807_CR77","doi-asserted-by":"crossref","first-page":"e000623","DOI":"10.1136\/bmjresp-2020-000623","volume":"7","author":"Z Li","year":"2020","unstructured":"Li Z et al (2020) Vimentin as a target for the treatment of COVID-19. BMJ open respiratory research 7(1):e000623","journal-title":"BMJ open respiratory research"},{"issue":"5","key":"2807_CR78","first-page":"2278","volume":"11","author":"Y-J Lai","year":"2021","unstructured":"Lai Y-J et al (2021) Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail. Am J Cancer Res 11(5):2278","journal-title":"Am J Cancer Res"},{"key":"2807_CR79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.matbio.2013.10.004","volume":"35","author":"HC Christianson","year":"2014","unstructured":"Christianson HC, Belting M (2014) Heparan sulfate proteoglycan as a cell-surface endocytosis receptor. Matrix Biol 35:51\u201355","journal-title":"Matrix Biol"},{"issue":"10","key":"2807_CR80","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/ac2001077","volume":"83","author":"W Wei","year":"2011","unstructured":"Wei W et al (2011) A comprehensive compositional analysis of heparin\/heparan sulfate-derived disaccharides from human serum. Anal Chem 83(10):3703\u20133708","journal-title":"Anal Chem"},{"issue":"7","key":"2807_CR81","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v11070596","volume":"11","author":"V Cagno","year":"2019","unstructured":"Cagno V et al (2019) Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses 11(7):596","journal-title":"Viruses"},{"issue":"4","key":"2807_CR82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen TM et al (2020) SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183(4):1043\u20131057","journal-title":"Cell"},{"issue":"1","key":"2807_CR83","first-page":"1","volume":"6","author":"Q Zhang","year":"2020","unstructured":"Zhang Q et al (2020) Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell discovery 6(1):1\u201314","journal-title":"Cell discovery"},{"issue":"4","key":"2807_CR84","first-page":"1043","volume":"183","author":"L Liu","year":"2021","unstructured":"Liu L et al (2021) Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2. ACS Central Science 183(4):1043","journal-title":"ACS Central Science"},{"issue":"52","key":"2807_CR85","doi-asserted-by":"crossref","first-page":"41143","DOI":"10.1074\/jbc.M110.153791","volume":"285","author":"NC Smits","year":"2010","unstructured":"Smits NC et al (2010) The heparan sulfate motif (GlcNS6S-IdoA2S) 3, common in heparin, has a strict topography and is involved in cell behavior and disease. J Biol Chem 285(52):41143\u201341151","journal-title":"J Biol Chem"},{"issue":"2","key":"2807_CR86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.hrtlng.2020.12.008","volume":"50","author":"HM Salah","year":"2021","unstructured":"Salah HM, Mehta JL (2021) Heparan sulfate consumption as a potential mechanism of intra-cardiac thrombosis in SARS-CoV-2 infection. Heart Lung 50(2):242\u2013243","journal-title":"Heart Lung"},{"issue":"4","key":"2807_CR87","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/vaccines7040171","volume":"7","author":"SS Park","year":"2019","unstructured":"Park SS (2019) Post-glycosylation modification of sialic acid and its role in virus pathogenesis. Vaccines 7(4):171","journal-title":"Vaccines"},{"issue":"2","key":"2807_CR88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/cells9020273","volume":"9","author":"X Zhou","year":"2020","unstructured":"Zhou X, Yang G, Guan F (2020) Biological functions and analytical strategies of sialic acids in tumor. Cells 9(2):273","journal-title":"Cells"},{"issue":"40","key":"2807_CR89","first-page":"E8508","volume":"114","author":"W Li","year":"2017","unstructured":"Li W et al (2017) Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci 114(40):E8508\u2013E8517","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"2807_CR90","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/acscentsci.0c00855","volume":"6","author":"AN Baker","year":"2020","unstructured":"Baker AN et al (2020) The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device. ACS Cent Sci 6(11):2046\u20132052","journal-title":"ACS Cent Sci"},{"issue":"1","key":"2807_CR91","first-page":"1","volume":"18","author":"L Nguyen","year":"2021","unstructured":"Nguyen L et al (2021) Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2. Nat Chem Biol. 18(1):1\u201310","journal-title":"Nat Chem Biol."},{"key":"2807_CR92","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S et al (2020) Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci 14:1004","journal-title":"Front Neurosci"},{"issue":"4","key":"2807_CR93","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/jmv.26776","volume":"93","author":"A Choudhury","year":"2021","unstructured":"Choudhury A et al (2021) In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humans. J Med Virol 93(4):2476\u20132486","journal-title":"J Med Virol"},{"issue":"2","key":"2807_CR94","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmv.26387","volume":"93","author":"R Patra","year":"2020","unstructured":"Patra R, Das NC, Mukherjee S (2020) Targeting human TLRs to combat COVID-19: a solution? J Med Virol 93(2):615\u2013617","journal-title":"J Med Virol"},{"issue":"5","key":"2807_CR95","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s43440-021-00245-z","volume":"73","author":"CS Kow","year":"2021","unstructured":"Kow CS et al (2021) The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep 73(5):1473\u20131479","journal-title":"Pharmacol Rep"},{"issue":"10","key":"2807_CR96","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/qjmed\/hcab247","volume":"114","author":"J Deng","year":"2021","unstructured":"Deng J et al (2021) Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis. QJM: Int J Med 114(10):721\u2013732","journal-title":"QJM: Int J Med"},{"issue":"8","key":"2807_CR97","doi-asserted-by":"crossref","first-page":"e3330","DOI":"10.1002\/dmrr.3330","volume":"36","author":"R Strollo","year":"2020","unstructured":"Strollo R, Pozzilli P (2020) DPP4 inhibition: preventing SARS-CoV-2 infection and\/or progression of COVID-19? Diabetes\/Metabol Res Rev 36(8):e3330","journal-title":"Diabetes\/Metabol Res Rev"},{"issue":"1","key":"2807_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-80464-1","volume":"11","author":"J Shilts","year":"2021","unstructured":"Shilts J et al (2021) No evidence for basigin\/CD147 as a direct SARS-CoV-2 spike binding receptor. Sci Rep 11(1):1\u201310","journal-title":"Sci Rep"},{"key":"2807_CR99","doi-asserted-by":"crossref","unstructured":"Suprewicz L. et al. (2021) Extracellular vimentin as a target against SARS-CoV-2 host cell invasion. bioRxiv.","DOI":"10.1101\/2021.01.08.425793"},{"key":"2807_CR100","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","volume":"11","author":"DB Kell","year":"2020","unstructured":"Kell DB, Heyden EL, Pretorius E (2020) The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front Immunol 11:1221","journal-title":"Front Immunol"},{"issue":"5","key":"2807_CR101","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/bloodadvances.2020003259","volume":"5","author":"S-C Wu","year":"2021","unstructured":"Wu S-C et al (2021) The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood Adv 5(5):1305","journal-title":"Blood Adv"},{"key":"2807_CR102","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2020.10.015","volume":"538","author":"J Fantini","year":"2021","unstructured":"Fantini J, Chahinian H, Yahi N (2021) Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19. Biochem Biophys Res Commun 538:132\u2013136","journal-title":"Biochem Biophys Res Commun"},{"key":"2807_CR103","first-page":"e922979","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X et al (2020) Interleukin 37 (IL-37) reduces high glucose-induced inflammation, oxidative stress, and apoptosis of podocytes by inhibiting the STAT3\u2013Cyclophilin A (CypA) signaling pathway. Med. Sci. 26:e922979\u2013e922981","journal-title":"Med. Sci."},{"key":"2807_CR104","doi-asserted-by":"crossref","unstructured":"Cantuni-Castelvetri L, Ojha, R, Pedro L (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system. bioRxiv.","DOI":"10.1101\/2020.06.07.137802"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02807-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-02807-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-02807-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T19:09:20Z","timestamp":1650136160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-02807-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["2807"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-02807-7","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"18 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"133"}}